IL132671A0 - Use of low-molecular-weight heparins for preventing and treating central nervous system trauma - Google Patents

Use of low-molecular-weight heparins for preventing and treating central nervous system trauma

Info

Publication number
IL132671A0
IL132671A0 IL13267198A IL13267198A IL132671A0 IL 132671 A0 IL132671 A0 IL 132671A0 IL 13267198 A IL13267198 A IL 13267198A IL 13267198 A IL13267198 A IL 13267198A IL 132671 A0 IL132671 A0 IL 132671A0
Authority
IL
Israel
Prior art keywords
molecular
preventing
low
nervous system
central nervous
Prior art date
Application number
IL13267198A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL132671A0 publication Critical patent/IL132671A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL13267198A 1997-05-28 1998-05-25 Use of low-molecular-weight heparins for preventing and treating central nervous system trauma IL132671A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706550A FR2763848B1 (fr) 1997-05-28 1997-05-28 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central
PCT/FR1998/001034 WO1998053833A1 (fr) 1997-05-28 1998-05-25 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central

Publications (1)

Publication Number Publication Date
IL132671A0 true IL132671A0 (en) 2001-03-19

Family

ID=9507335

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13267198A IL132671A0 (en) 1997-05-28 1998-05-25 Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
IL132671A IL132671A (en) 1997-05-28 1999-11-01 Use of low molecular weight perins for the preparation of drugs for the prevention and treatment of trauma of the central nervous system

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL132671A IL132671A (en) 1997-05-28 1999-11-01 Use of low molecular weight perins for the preparation of drugs for the prevention and treatment of trauma of the central nervous system

Country Status (24)

Country Link
US (1) US6380173B1 (xx)
EP (2) EP0984786B1 (xx)
JP (1) JP2002500660A (xx)
KR (1) KR100531721B1 (xx)
CN (1) CN1212845C (xx)
AR (1) AR012876A1 (xx)
AT (1) ATE276752T1 (xx)
AU (1) AU752322B2 (xx)
BR (1) BR9809504A (xx)
CA (1) CA2290675A1 (xx)
DE (1) DE69826460T2 (xx)
ES (1) ES2227841T3 (xx)
FR (1) FR2763848B1 (xx)
IL (2) IL132671A0 (xx)
MA (1) MA24553A1 (xx)
NO (1) NO317517B1 (xx)
NZ (1) NZ501365A (xx)
PE (1) PE74699A1 (xx)
PT (1) PT984786E (xx)
RU (1) RU2215531C2 (xx)
TN (1) TNSN98071A1 (xx)
TW (1) TW533075B (xx)
WO (1) WO1998053833A1 (xx)
ZA (1) ZA984432B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010041686A1 (en) * 2000-01-06 2001-11-15 Veronique Mary Novel therapeutic application of enoxaparin
US9308220B2 (en) 2001-12-11 2016-04-12 Cosmo Technologies Limited Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
ITMI20012599A1 (it) * 2001-12-11 2003-06-11 Cosmo Spa Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
US7511026B2 (en) 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA829463B (en) * 1982-07-19 1983-10-26 Hepar Ind Inc Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
IT1264530B (it) * 1992-07-31 1996-10-02 Crinos Industria Farmaco Impiego dei polisaccaridi nelle neuropatie atrofico degenerative

Also Published As

Publication number Publication date
ES2227841T3 (es) 2005-04-01
TW533075B (en) 2003-05-21
TNSN98071A1 (fr) 2005-03-15
FR2763848B1 (fr) 2000-01-28
DE69826460D1 (de) 2004-10-28
IL132671A (en) 2007-06-17
DE69826460T2 (de) 2005-10-13
PE74699A1 (es) 1999-10-21
NO995538D0 (no) 1999-11-12
EP0984786A1 (fr) 2000-03-15
RU2215531C2 (ru) 2003-11-10
KR20010012988A (ko) 2001-02-26
JP2002500660A (ja) 2002-01-08
AR012876A1 (es) 2000-11-22
KR100531721B1 (ko) 2005-11-28
US6380173B1 (en) 2002-04-30
NO317517B1 (no) 2004-11-08
ATE276752T1 (de) 2004-10-15
CA2290675A1 (fr) 1998-12-03
CN1257428A (zh) 2000-06-21
CN1212845C (zh) 2005-08-03
BR9809504A (pt) 2000-06-20
FR2763848A1 (fr) 1998-12-04
MA24553A1 (fr) 1998-12-31
NZ501365A (en) 2002-12-20
EP0984786B1 (fr) 2004-09-22
WO1998053833A1 (fr) 1998-12-03
PT984786E (pt) 2005-01-31
ZA984432B (en) 1998-12-02
EP1421943A1 (fr) 2004-05-26
NO995538L (no) 1999-11-12
AU752322B2 (en) 2002-09-19
AU7775998A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
ZA965088B (en) Methods of preventing or treating allergles
EP0766651A4 (en) METHOD AND SYSTEM FOR REGULATED DENITRIFICATION
GB9624256D0 (en) Watere treatment process and system
SG55323A1 (en) Substrate treating system and substrate treating method
GB9506926D0 (en) Cystine-siicone copolymers and their use for treating keratin substrates
SG65015A1 (en) Substrate treatment system
IL134718A0 (en) Treatment of conduct disorder
GB9603747D0 (en) Treatment of liquors
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
NZ304245A (en) Effluent treatment system
PL314893A1 (en) Sewage treatment system and method
AU2807297A (en) Methods of treating wastewater
AU1212097A (en) Method and system for the treatment of livestock wastewater
IL132671A0 (en) Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
EP0921803A4 (en) METHOD FOR PREVENTING AND TREATING PESTVIRUS INFECTIONS AND RELATED DISEASES
HUP9700661A3 (en) Use of alpha-1-adrenoreceptor antagonists for the production of pharmaceuticals for profilacting and treating cancer
AU2002300292A1 (en) Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
PL331283A1 (en) Preparation for treating and/or preventing stupefaction
GB9317943D0 (en) Treatment of laminitis
IL119282A (en) Treatment of fowl
AU4264393A (en) Combined animal bath, shower and drier
EP0880468A4 (en) TREATMENT OF BAUXITE
GB9622609D0 (en) Treatment of paralysis or muscle disorder
AU1612499A (en) Method for treating or preventing psychosomatic and psychoimmunologic disorders
GB9317989D0 (en) Treatment of laminitis

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed